Hydrocortisone Sodium Succinate from Japan
Hydrocortisone sodium succinate is a water-soluble salt of hydrocortisone succinic acid ester, used intravenously for acute inflammation and adrenal crisis treatment. Classified under HTS 2937.29.90.20 as a salt and ester derivative of hydrocortisone used primarily as a hormone.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Include stability data and sterility assurance documentation for injectable-grade material; maintain cold chain during transport
• Verify sodium salt content via HPLC analysis in CoA to confirm classification as hydrocortisone derivative
• Avoid packaging in single-dose vials which could trigger Chapter 30 classification as finished medicaments